skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR Guide for Energy and Plant Managers

Abstract

The U.S. pharmaceutical industry consumes almost $1 billion in energy annually. Energy efficiency improvement is an important way to reduce these costs and to increase predictable earnings, especially in times of high energy price volatility. There are a variety of opportunities available at individual plants in the U.S. pharmaceutical industry to reduce energy consumption in a cost-effective manner. This Energy Guide discusses energy efficiency practices and energy efficient technologies that can be implemented at the component, process, system, and organizational levels. A discussion of the trends, structure, and energy consumption characteristics of the U.S. pharmaceutical industry is provided along with a description of the major process steps in the pharmaceutical manufacturing process. Expected savings in energy and energy-related costs are given for many energy efficiency measures, based on case study data from real-world applications in pharmaceutical and related facilities worldwide. Typical measure payback periods and references to further information in the technical literature are also provided, when available. The information in this Energy Guide is intended to help energy and plant managers reduce energy consumption in a cost-effective manner while meeting regulatory requirements and maintaining the quality of products manufactured. At individual plants, further research on the economics of themore » measures?as well as their applicability to different production practices?is needed to assess potential implementation of selected technologies.« less

Authors:
; ; ; ;
Publication Date:
Research Org.:
Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
Sponsoring Org.:
Environmental Energy Technologies Division
OSTI Identifier:
929403
Report Number(s):
LBNL-57260-Revision
TRN: US200822%%974
DOE Contract Number:  
DE-AC02-05CH11231
Resource Type:
Technical Report
Country of Publication:
United States
Language:
English
Subject:
32; DRUGS; ECONOMICS; ENERGY CONSUMPTION; ENERGY EFFICIENCY; ENERGY EFFICIENCY STANDARDS; IMPLEMENTATION; INDUSTRY; INFORMATION; MANUFACTURING; PAYBACK PERIOD; Pharmaceutical Industry, Energy Star, Cost Savings

Citation Formats

Galitsky, Christina, Galitsky, Christina, Chang, Sheng-chieh, Worrell, Ernst, and Masanet, Eric. Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR Guide for Energy and Plant Managers. United States: N. p., 2008. Web. doi:10.2172/929403.
Galitsky, Christina, Galitsky, Christina, Chang, Sheng-chieh, Worrell, Ernst, & Masanet, Eric. Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR Guide for Energy and Plant Managers. United States. https://doi.org/10.2172/929403
Galitsky, Christina, Galitsky, Christina, Chang, Sheng-chieh, Worrell, Ernst, and Masanet, Eric. 2008. "Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR Guide for Energy and Plant Managers". United States. https://doi.org/10.2172/929403. https://www.osti.gov/servlets/purl/929403.
@article{osti_929403,
title = {Energy Efficiency Improvement and Cost Saving Opportunities for the Pharmaceutical Industry. An ENERGY STAR Guide for Energy and Plant Managers},
author = {Galitsky, Christina and Galitsky, Christina and Chang, Sheng-chieh and Worrell, Ernst and Masanet, Eric},
abstractNote = {The U.S. pharmaceutical industry consumes almost $1 billion in energy annually. Energy efficiency improvement is an important way to reduce these costs and to increase predictable earnings, especially in times of high energy price volatility. There are a variety of opportunities available at individual plants in the U.S. pharmaceutical industry to reduce energy consumption in a cost-effective manner. This Energy Guide discusses energy efficiency practices and energy efficient technologies that can be implemented at the component, process, system, and organizational levels. A discussion of the trends, structure, and energy consumption characteristics of the U.S. pharmaceutical industry is provided along with a description of the major process steps in the pharmaceutical manufacturing process. Expected savings in energy and energy-related costs are given for many energy efficiency measures, based on case study data from real-world applications in pharmaceutical and related facilities worldwide. Typical measure payback periods and references to further information in the technical literature are also provided, when available. The information in this Energy Guide is intended to help energy and plant managers reduce energy consumption in a cost-effective manner while meeting regulatory requirements and maintaining the quality of products manufactured. At individual plants, further research on the economics of the measures?as well as their applicability to different production practices?is needed to assess potential implementation of selected technologies.},
doi = {10.2172/929403},
url = {https://www.osti.gov/biblio/929403}, journal = {},
number = ,
volume = ,
place = {United States},
year = {2008},
month = {3}
}